Lenalidomide Combined With G-CHOP in the Treatment of Newly Diagnosed DLBCL With FL
Status:
Recruiting
Trial end date:
2026-12-31
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy and adverse effects of lenalidomide combined with G-CHOP(LO-CHOP) in
the treatment of newly diagnosed diffuse large B-cell lymphoma with follicular lymphoma
(CDLBCL-FL).
Phase:
Phase 2
Details
Lead Sponsor:
The First Affiliated Hospital of Xiamen University
Collaborators:
Fujian Cancer Hospital Jiangxi Provincial Cancer Hospital Sun Yat-sen University The First Affiliated Hospital with Nanjing Medical University